These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 2318247)
1. Inhibition of T lymphocyte heparanase by heparin prevents T cell migration and T cell-mediated immunity. Lider O; Mekori YA; Miller T; Bar-Tana R; Vlodavsky I; Baharav E; Cohen IR; Naparstek Y Eur J Immunol; 1990 Mar; 20(3):493-9. PubMed ID: 2318247 [TBL] [Abstract][Full Text] [Related]
2. Differential effects of polysulfated polysaccharide on experimental encephalomyelitis, proliferation of autoimmune T cells, and inhibition of heparanase activity. Hershkoviz R; Mor F; Miao HQ; Vlodavsky I; Lider O J Autoimmun; 1995 Oct; 8(5):741-50. PubMed ID: 8579728 [TBL] [Abstract][Full Text] [Related]
3. Murine macrophage heparanase: inhibition and comparison with metastatic tumor cells. Savion N; Disatnik MH; Nevo Z J Cell Physiol; 1987 Jan; 130(1):77-84. PubMed ID: 3805131 [TBL] [Abstract][Full Text] [Related]
4. Soluble antigen induces T lymphocytes to secrete an endoglycosidase that degrades the heparan sulfate moiety of subendothelial extracellular matrix. Fridman R; Lider O; Naparstek Y; Fuks Z; Vlodavsky I; Cohen IR J Cell Physiol; 1987 Jan; 130(1):85-92. PubMed ID: 2433294 [TBL] [Abstract][Full Text] [Related]
5. Structural requirements for inhibition of melanoma lung colonization by heparanase inhibiting species of heparin. Bitan M; Mohsen M; Levi E; Wygoda MR; Miao HQ; Lider O; Svahn CM; Ekre HP; Ishai-Michaeli R; Bar-Shavit R Isr J Med Sci; 1995; 31(2-3):106-18. PubMed ID: 7744578 [TBL] [Abstract][Full Text] [Related]
6. Expression of heparanase by platelets and circulating cells of the immune system: possible involvement in diapedesis and extravasation. Vlodavsky I; Eldor A; Haimovitz-Friedman A; Matzner Y; Ishai-Michaeli R; Lider O; Naparstek Y; Cohen IR; Fuks Z Invasion Metastasis; 1992; 12(2):112-27. PubMed ID: 1399400 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of tumor metastasis by heparanase inhibiting species of heparin. Vlodavsky I; Mohsen M; Lider O; Svahn CM; Ekre HP; Vigoda M; Ishai-Michaeli R; Peretz T Invasion Metastasis; 1994-1995; 14(1-6):290-302. PubMed ID: 7657522 [TBL] [Abstract][Full Text] [Related]
8. T cell responses induced by the parenteral injection of antigen-modified syngeneic cells. I. Induction, characterization, and regulation of antigen-specific T helper cells involved in delayed-type hypersensitivity responses. Miller SD; Butler LD J Immunol; 1983 Jul; 131(1):77-85. PubMed ID: 6190929 [TBL] [Abstract][Full Text] [Related]
9. Lung colonization by and heparanase activity in in vitro transformed 3T3 cells rendered highly tumorigenic by an in vivo passage. Katz BZ; Ishai-Michaeli R; Zusman T; Vlodavsky I; Witz IP Invasion Metastasis; 1994-1995; 14(1-6):276-89. PubMed ID: 7657521 [TBL] [Abstract][Full Text] [Related]
10. Mechanisms of suppressed cell-mediated immunity and impaired antigen-induced interleukin 2 production in granuloma-bearing mice. Kobayashi K; Allred C; Yoshida T J Immunol; 1985 Nov; 135(5):2996-3003. PubMed ID: 2931477 [TBL] [Abstract][Full Text] [Related]
11. Characterization of two different Ly-1+ T cell populations that mediate delayed-type hypersensitivity. Van Loveren H; Kato K; Meade R; Green DR; Horowitz M; Ptak W; Askenase PW J Immunol; 1984 Nov; 133(5):2402-11. PubMed ID: 6332850 [TBL] [Abstract][Full Text] [Related]
12. In vitro T cell-mediated killing of Pseudomonas aeruginosa. V. Generation of bactericidal T cells in nonresponder mice. Powderly WG; Pier GB; Markham RB J Immunol; 1987 Apr; 138(7):2272-7. PubMed ID: 2951437 [TBL] [Abstract][Full Text] [Related]
13. Suppression of experimental autoimmune diseases and prolongation of allograft survival by treatment of animals with low doses of heparins. Lider O; Baharav E; Mekori YA; Miller T; Naparstek Y; Vlodavsky I; Cohen IR J Clin Invest; 1989 Mar; 83(3):752-6. PubMed ID: 2493485 [TBL] [Abstract][Full Text] [Related]
14. Site-selective homing of antigen-primed lymphocyte populations can play a crucial role in the efferent limb of cell-mediated immune responses in vivo. Spangrude GJ; Araneo BA; Daynes RA J Immunol; 1985 May; 134(5):2900-7. PubMed ID: 4038988 [TBL] [Abstract][Full Text] [Related]
15. Periplocoside E, an effective compound from Periploca sepium Bge, inhibited T cell activation in vitro and in vivo. Zhu YN; Zhao WM; Yang YF; Liu QF; Zhou Y; Tian J; Ni J; Fu YF; Zhong XG; Tang W; Zhou R; He PL; Li XY; Zuo JP J Pharmacol Exp Ther; 2006 Feb; 316(2):662-9. PubMed ID: 16204471 [TBL] [Abstract][Full Text] [Related]
16. Lymphocyte recruitment in delayed-type hypersensitivity. The role of IFN-gamma. Issekutz TB; Stoltz JM; vd Meide P J Immunol; 1988 May; 140(9):2989-93. PubMed ID: 3129506 [TBL] [Abstract][Full Text] [Related]
17. T cells expressing delayed-type hypersensitivity can be derived from a humorally immune lymphocyte population. LeClercq SA; Bretscher PA Eur J Immunol; 1987 Jul; 17(7):949-54. PubMed ID: 3497043 [TBL] [Abstract][Full Text] [Related]
18. Role of heparanase in platelet and tumor cell interactions with the subendothelial extracellular matrix. Eldor A; Bar-Ner M; Yahalom J; Fuks Z; Vlodavsky I Semin Thromb Hemost; 1987 Oct; 13(4):475-88. PubMed ID: 3321438 [TBL] [Abstract][Full Text] [Related]
19. The in vivo behavior of T cell clones: altered migration due to loss of the lymphocyte surface homing receptor. Dailey MO; Gallatin WM; Weissman IL J Mol Cell Immunol; 1985; 2(1):27-36. PubMed ID: 2978224 [TBL] [Abstract][Full Text] [Related]
20. Involvement of both heparanase and plasminogen activator in lymphoma cell-mediated degradation of heparan sulfate in the subendothelial extracellular matrix. Bar-Ner M; Mayer M; Schirrmacher V; Vlodavsky I J Cell Physiol; 1986 Aug; 128(2):299-306. PubMed ID: 2426287 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]